angiotensin II-receptor blocker, olmesartan 40 mg /24h
DISEASE INTERVENTION COMPARISON RESULTS
N Engl J Med. 2011 Mar 10;364(10):907-17 Randomized Controlled Trial, Multicenter Study
IN diabetes mellitus, type 2, without proteinuria The Use of
angiotensin II-receptor blocker, olmesartan 40 mg /24h
As Treatment, Chronic
Is better Than
placebo
To reduce at 3.2 years the number of patients with microalbuminuria: 8.2% olmesartan VS 9.8% placebo